Mostrar el registro sencillo del ítem

dc.contributor.authorMartínez López, Icíar
dc.contributor.authorGOMEZ CEREZO, JORGE FRANCISCO
dc.contributor.authorGámez, José Mª
dc.contributor.authorEgocheaga Cabello, Isabel
dc.contributor.authorCastellanos, María del Mar
dc.contributor.authorCampuzano Ruiz, Raquel
dc.contributor.authorbarrios, vivencio
dc.contributor.authorPallarés-Carratalá, Vicente
dc.contributor.authorRodríguez, José Manuel
dc.contributor.authorMorant Talamante, Nuria
dc.contributor.authorParrondo, Javier
dc.contributor.authorMostaza, José María
dc.date.accessioned2024-02-29T13:12:16Z
dc.date.available2024-02-29T13:12:16Z
dc.date.issued2024
dc.identifier.citationMartínez López I, Gómez Cerezo JF, Gámez JM, Egocheaga Cabello I, Castellanos M, Campuzano Ruiz R, Barrios V, PallarésCarratalá V, Rodríguez JM, Morant Talamante N, Parrondo J and Mostaza JM (2024) Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain. Front. Cardiovasc. Med. 11:1324537. doi: 10.3389/fcvm.2024.1324537ca_CA
dc.identifier.issn2297-055X
dc.identifier.urihttp://hdl.handle.net/10234/206083
dc.description.abstractIntroduction: Atherosclerotic cardiovascular disease (ASCVD) is one of the main causes of morbidity and mortality in developed countries and entails high resources use and costs for health systems. The risk of suffering future cardiovascular (CV) events and the consequent resources use is higher in those patients who have already had a previous cardiovascular event. The objective of the study was to determine the average annual cost of patients with a new or recurrent atherosclerotic CV event during the 2 years after the event. Methodology: Retrospective observational study of electronic medical records of patients from the BIG-PAC® database (7 integrated health areas of 7 Autonomous Communities; n = 1.8 million). Patients with a new or recurrent episode of ASCVD (angina, acute myocardial infarction, transient ischemic attack, stroke, or peripheral arterial disease) between 1-Jan-2017 and 31-Dec2018 were included. The resources use within two years of the diagnosis was estimated in order to estimate the average cost of patient follow-up. Results: A total of 26,976 patients with an ASCVD episode were identified during the recruitment period; Out of them, 6,798 had a recurrent event during the follow-up period and 2,414 died. The average costs per patient were €11,171 during the first year and €9,944 during the second year. Discussion: Patients with ASCVD represent a significant economic burden for the health system and for society. Despite the perception that drug costs in the followup of chronic patients imply a high percentage of the costs, these accounted for only one tenth of the total amount. Implementing preventive programs and increasing the control of cardiovascular risk factors may have a significant social and health impact by helping to reduce mortality and costs for the Spanish National Health System. The costs derived from pharmacological treatments were obtained from the NHS pricing nomenclator database (https://www.sanidad.gob.es/profesionales/nomenclator.do).ca_CA
dc.format.extent8 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherFrontiersca_CA
dc.relation.isPartOfFrontiers in Cardiovascular Medicine 11:1324537ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca_CA
dc.subjectcost of illnessca_CA
dc.subjecthypercholesterolemiaca_CA
dc.subjectatherosclerosisca_CA
dc.subjectobservational studyca_CA
dc.subjectelectronic health recordsca_CA
dc.titlePost-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spainca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.3389/fcvm.2024.1324537
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como: http://creativecommons.org/licenses/by/4.0/